Rankings
▼
Calendar
CRON Q3 2022 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena
CRON
Cronos Group Inc.
$983M
Q3 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$28M
+38.1% YoY
Gross Profit
$4M
15.4% margin
Operating Income
-$38M
-133.9% margin
Net Income
-$51M
-181.2% margin
EPS (Diluted)
$-0.10
QoQ Revenue Growth
+1.4%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$15M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$1.7B
Total Liabilities
$64M
Stockholders' Equity
$1.6B
Cash & Equivalents
$875M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$28M
$20M
+38.1%
Gross Profit
$4M
-$730,000
+694.8%
Operating Income
-$38M
-$56M
+33.1%
Net Income
-$51M
$78M
-165.6%
Revenue Segments
Cannabis Flower
$14M
65%
Cannabis Extracts
$7M
34%
Product and Service, Other
$108,000
1%
Geographic Segments
CANADA
$13M
64%
ISRAEL
$7M
34%
UNITED STATES
$514,000
2%
← FY 2022
All Quarters
Q4 2022 →